REGENXBIO Inc 10-K for FY2021
REGENXBIO Inc. (RGNX)
10-K
2022-03-01
For: 2021-12-31
View Original
Added on
April 06, 2026
About this 10-K
REGENXBIO Inc filed this 10-K on March 1, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $470.35M
- up 204.3% from $154.57M a year earlier
- Net income
- $127.84M
- compared with a net loss of $111.25M a year earlier
- Diluted EPS
- $2.91
- compared with -$2.98 a year earlier